Form 8-K - Current report:
SEC Accession No. 0001193125-25-273266
Filing Date
2025-11-10
Accepted
2025-11-10 07:32:25
Documents
13
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20251110.htm   iXBRL 8-K 42216
2 EX-99.1 agen-ex99_1.htm EX-99.1 34029
3 GRAPHIC img250783414_0.jpg GRAPHIC 4985
4 GRAPHIC img250783414_1.jpg GRAPHIC 110994
  Complete submission text file 0001193125-25-273266.txt   345007

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20251110.xsd EX-101.SCH 23893
15 EXTRACTED XBRL INSTANCE DOCUMENT agen-20251110_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 251464352
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)